Standard BioTools Inc.
LAB
$1.50
$0.074.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.69M | -33.46M | -26.03M | -34.07M | -26.94M |
| Total Depreciation and Amortization | 1.60M | 3.99M | 4.17M | 3.95M | -448.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.42M | 7.72M | 7.17M | 8.05M | 10.21M |
| Change in Net Operating Assets | 471.00K | 1.08M | -15.60M | 8.02M | -10.69M |
| Cash from Operations | -22.20M | -20.67M | -30.28M | -14.06M | -27.87M |
| Capital Expenditure | -886.00K | -1.89M | -5.05M | -3.38M | -2.26M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -1.39M | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.80M | 29.39M | 19.68M | 30.49M | -28.63M |
| Cash from Investing | -6.68M | 27.51M | 14.63M | 25.73M | -30.88M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -55.00M | 0.00 |
| Issuance of Common Stock | 0.00 | 308.00K | -- | 525.00K | 68.00K |
| Repurchase of Common Stock | -112.00K | -200.00K | -46.00K | -45.00K | -70.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | -112.00K | 108.00K | -46.00K | -54.52M | -2.00K |
| Foreign Exchange rate Adjustments | -203.00K | 788.00K | 357.00K | -267.00K | -408.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.20M | 7.73M | -15.35M | -43.12M | -59.16M |